Sandoval Micaela N, Klawans Michelle R, Bach MacKinsey A, Mikhail Jennifer, Graviss Edward A, Cao Tru, Parchem Jacqueline G, Husain Junaid, Boerwinkle Eric
Department of Epidemiology, University of Texas Health Science Center at Houston School of Public Health, 1200 Pressler Street, Houston, TX, 77006, USA.
Healthconnect Texas, Houston, TX, USA.
BMC Med. 2025 May 9;23(1):274. doi: 10.1186/s12916-025-04094-y.
BACKGROUND: The effects of SARS-CoV-2 infection before or during pregnancy on pregnancy outcomes are still largely unknown. We hypothesized that COVID-19 in early pregnancy is a risk factor for adverse pregnancy outcomes, particularly miscarriage. METHODS: We examined the relationship between COVID-19 and adverse pregnancy outcomes, including spontaneous abortion, ectopic pregnancy, and preterm delivery in a large, retrospective, electronic health record (EHR)-based cohort, from 2019 to 2023. Generalized estimating equation modeling was performed to identify risk factors for adverse pregnancy outcomes. Study exposures included COVID-19 before pregnancy, COVID-19 during pregnancy, age, race/ethnicity, comorbidity burden, and neighborhood-level social vulnerability. RESULTS: In the Southeast Texas Pregnancy and COVID Cohort (26,783 pregnancy episodes), the risk of miscarriage among pregnancy episodes with a miscarriage, livebirth, or delivery outcome was 6.3% (1514/ 24,119). In multivariable modeling, history of both mild and moderate to severe COVID-19 before pregnancy were associated with miscarriage (adjusted odds ratio (aOR) 2.48, confidence interval (CI) 2.21-2.78 and aOR 2.81, CI 1.8-4.38, respectively). Additionally, in the same model, both mild and moderate to severe COVID-19 in the first trimester were associated with miscarriage (aOR 2.31, CI 1.96-2.72 and aOR 2.45, CI 1.12-5.35, respectively). CONCLUSIONS: COVID-19 both prior to and during pregnancy was identified as a risk factor for spontaneous abortion in this study sample. These findings highlight the importance of COVID-19 vaccination and post-COVID management for pregnant people and those planning a pregnancy.
Am J Obstet Gynecol MFM. 2020-5
J Ovarian Res. 2025-7-18
J Allergy Clin Immunol. 2025-4
JAMA Netw Open. 2024-12-2
Biomed Rep. 2024-11-19
BMC Public Health. 2024-11-13
Matern Health Neonatol Perinatol. 2024-10-1